After US approval, Japan OKs its first Alzheimer’s drug. Leqembi was developed by Eisai and Biogen
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies ByMARI YAMAGUCHI Associated Press September 26, 2023, 2:18 AM This undated image made from video provided by Eisai Co., Ltd., shows Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and … Read more